Boots to start prescribing medical cannabis in first for UK high street pharmacy




Dr David Gwynne, the medical director of Boots’ online doctor service, emphasised that the drug would not suit every patient and that prescribing choices required careful, case-by-case judgement.“SureLeaf has, therefore, been designed with strong clinical safeguards and specialist oversight at every stage, so treatment is only considered for patients where it is clinically appropriate,” he said. The pharmacy’s medical director insisted that responsible, clinician-led care would extend from initial assessment through to continued monitoring. Today’s announcement comes after Whittington Investments, the Canadian holding company of the Weston family, took over Boots. Canada has permitted medicinal cannabis since 2001 and established a legal recreational market in 2018.